Style | Citing Format |
---|---|
MLA | Zarezardini H, et al.. "Antimicrobial Peptides As Potent Compounds for Reduction of Covid-19 Infection." Bulletin of Pharmaceutical Sciences. Assiut, vol. 44, no. 1, 2021, pp. 243-252. |
APA | Zarezardini H, Ferdosian F, Soltaninejad H, Zahedi M, Memarpooryazdi M, Hamidieh AA, Aghaeimeybodi F, Zarezadeh M, Eshaghi FS, Jabinian F, Dehghanbaghi N, Mirakhor M, Khnjarpanah Z (2021). Antimicrobial Peptides As Potent Compounds for Reduction of Covid-19 Infection. Bulletin of Pharmaceutical Sciences. Assiut, 44(1), 243-252. |
Chicago | Zarezardini H, Ferdosian F, Soltaninejad H, Zahedi M, Memarpooryazdi M, Hamidieh AA, Aghaeimeybodi F, et al.. "Antimicrobial Peptides As Potent Compounds for Reduction of Covid-19 Infection." Bulletin of Pharmaceutical Sciences. Assiut 44, no. 1 (2021): 243-252. |
Harvard | Zarezardini H et al. (2021) 'Antimicrobial Peptides As Potent Compounds for Reduction of Covid-19 Infection', Bulletin of Pharmaceutical Sciences. Assiut, 44(1), pp. 243-252. |
Vancouver | Zarezardini H, Ferdosian F, Soltaninejad H, Zahedi M, Memarpooryazdi M, Hamidieh AA, et al.. Antimicrobial Peptides As Potent Compounds for Reduction of Covid-19 Infection. Bulletin of Pharmaceutical Sciences. Assiut. 2021;44(1):243-252. |
BibTex | @article{ author = {Zarezardini H and Ferdosian F and Soltaninejad H and Zahedi M and Memarpooryazdi M and Hamidieh AA and Aghaeimeybodi F and Zarezadeh M and Eshaghi FS and Jabinian F and Dehghanbaghi N and Mirakhor M and Khnjarpanah Z}, title = {Antimicrobial Peptides As Potent Compounds for Reduction of Covid-19 Infection}, journal = {Bulletin of Pharmaceutical Sciences. Assiut}, volume = {44}, number = {1}, pages = {243-252}, year = {2021} } |
RIS | TY - JOUR AU - Zarezardini H AU - Ferdosian F AU - Soltaninejad H AU - Zahedi M AU - Memarpooryazdi M AU - Hamidieh AA AU - Aghaeimeybodi F AU - Zarezadeh M AU - Eshaghi FS AU - Jabinian F AU - Dehghanbaghi N AU - Mirakhor M AU - Khnjarpanah Z TI - Antimicrobial Peptides As Potent Compounds for Reduction of Covid-19 Infection JO - Bulletin of Pharmaceutical Sciences. Assiut VL - 44 IS - 1 SP - 243 EP - 252 PY - 2021 ER - |